MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
16.66
-0.19 (-1.13%)
At close: Apr 28, 2026, 4:00 PM EDT
16.60
-0.06 (-0.36%)
Pre-market: Apr 29, 2026, 5:10 AM EDT
MLTX Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,195 | 941 | 3,415 | 3,620 | 409 | - |
| Market Cap Growth | -44.41% | -72.45% | -5.66% | 784.47% | - | - |
| Enterprise Value | 877 | 638 | 2,932 | 3,189 | 353 | - |
| Last Close Price | 16.66 | 13.18 | 54.15 | 60.39 | 10.50 | 9.89 |
| PB Ratio | 3.91 | 3.09 | 7.53 | 7.05 | 5.95 | - |
| P/TBV Ratio | 3.92 | 3.09 | 7.64 | 7.30 | 8.37 | - |
| Debt / Equity Ratio | 0.25 | 0.25 | 0.01 | 0.01 | 0.00 | -1.29 |
| Net Debt / Equity Ratio | -1.04 | -1.04 | -0.98 | -0.99 | -1.04 | -0.60 |
| Net Debt / EBITDA Ratio | 1.31 | 1.31 | 3.14 | 9.44 | 1.11 | -0.20 |
| Net Debt / FCF Ratio | 1.62 | 1.62 | 3.80 | 11.78 | 1.29 | -0.16 |
| Quick Ratio | 8.77 | 8.77 | 20.07 | 51.38 | 9.44 | 0.39 |
| Current Ratio | 9.27 | 9.27 | 21.11 | 51.59 | 9.98 | 0.46 |
| Return on Equity (ROE) | -60.78% | -60.78% | -25.08% | -15.14% | -225.86% | - |
| Return on Assets (ROA) | -33.92% | -33.92% | -17.81% | -11.21% | -93.99% | - |
| Return on Capital Employed (ROCE) | -64.60% | -64.60% | -31.40% | -10.50% | -94.00% | 300.70% |
| Earnings Yield | -19.02% | -24.16% | -3.48% | -1.00% | -12.21% | - |
| FCF Yield | -16.41% | -20.84% | -3.43% | -1.19% | -13.66% | - |
| Buyback Yield / Dilution | -2.54% | -2.54% | -27.99% | -67.30% | -274.47% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.